Skip to main content
. 2014 Dec 1;6(2):1302–1314. doi: 10.18632/oncotarget.2744

Table 1. Gene targets.

Gene TAQMAN Assay ID (Life Technologies)
Tumor marker
upregulated
ADAM2 [20] HS00155182_m1
AMACR [6] Hs01091292_m1
TMEFF2 [21] Hs01086906_m1
HPN [22] Hs01056332_m1
HOXC6 [23] Hs00171690_m1
CAMKK2 [24] Hs00198032_m1
ABCC4 [25] Hs00988717_m1
REPS2 [26] Hs00190932_m1
downregulated
LAMB3 [27] Hs00165078_m1
S100A14 [28] Hs04189107_g1
ITPKA [29] Hs00176658_m1
GATA3 [30] Hs00231122_m1
Epithelial Mesenchymal Transition (EMT) marker
upregulated
ZEB1 [31] Hs00232783_m1
SNAIL1 [32] Hs00195591_m1
SNAIL2 [32] Hs00950344_m1
TWIST [32] Hs00361186_m1
MIR200c [32] Hs04231534_s1
Stemness marker
upregulated
SOX2 [33] Hs01053049_s1
SOX9 [34] Hs01001343_g1
ALDH1 [35] Hs00946916_m1
BMI1 [36] Hs00995536_m1
OCT-4 [37] Hs00999634_gH
NANOG [37] Hs02387400_g1
Lineage marker
upregulated
Vimentin [38] Hs00185584_m1
CXCR4 [39] Hs00237052_m1
CD45 [40] Hs04189704_m1
AR [41] Hs00171172_m1
Additional Lineage marker
upregulated
Epcam Hs00901885_m1
KRT5 [42] Hs00361185_m1
KRT8 [42] Hs01595539_g1
P63 [42] Hs00978343_m1